Citation Impact
Citing Papers
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
2000
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Management of Stroke in Infants and Children
2008
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
2009 Standout
IL-10: The Master Regulator of Immunity to Infection
2008 Standout
Heparin-induced thrombocytopenia (HIT)
2006
Deep venous thrombosis in medical–surgical ICU patients: prevalence, incidence and risk factors
2003
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Relationship between peak anti-Xa levels and calculated creatinine clearance in ICU patients receiving low molecular weight heparin
2003
Growth hormone improves height in patients with juvenile idiopathic arthritis: 4-year data of a controlled study
2003
Dysfunction of Endothelial Protein C Activation in Severe Meningococcal Sepsis
2001
Mechanisms of Thrombus Formation
2008 Standout
Immunology of the antiphospholipid antibody syndrome
1996
4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease
1999
Treatment of Warfarin-Associated Intracerebral Hemorrhage: Literature Review and Expert Opinion
2007
Intracerebral haemorrhage
2009 Standout
A randomized, placebo‐controlled, double‐masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis
2005
Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation.
1997
Mechanisms linking obesity with cardiovascular disease
2006 StandoutNature
The complex interaction between obesity, metabolic syndrome and reproductive axis: A narrative review
2012
Pathogenesis of human parvovirus B19 in rheumatic disease
2000
Etanercept in Children with Polyarticular Juvenile Rheumatoid Arthritis
2000
Platelet-rich plasma: evidence to support its use
2004 Standout
Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation
2000
Juvenile idiopathic arthritis
2007 Standout
Inflamm‐aging: An Evolutionary Perspective on Immunosenescence
2000 Standout
Alveolar Ridge and Sinus Augmentation Utilizing Platelet‐Rich Plasma in Combination With Freeze‐Dried Bone Allograft: Case Series
2000
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
IL-6 as a keystone cytokine in health and disease
2015 Standout
Reduction in case fatality rate from meningococcal disease associated with improved healthcare delivery
2001
Selective Increase in Plasma Tumor Necrosis Factor- and Concomitant Clinical Deterioration after Initiating Therapy in Patients with Severe Tuberculosis
1998
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.
1998 Standout
Obesity
2005 Standout
Mammalian display screening of diverse cystine-dense peptides for difficult to drug targets
2017 StandoutNobel
Phagocyte-specific calcium-binding S100 proteins as clinical laboratory markers of inflammation
2004
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Antithrombotic Therapy for VTE Disease
2012 Standout
Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study
2009 StandoutNobel
Maternal and child undernutrition: global and regional exposures and health consequences
2008 Standout
Coagulation and fibrinolysis abnormalities in obesity
2002
Heparin-Induced Thrombocytopenia
2006 Standout
The Antiphospholipid Syndrome
2002 Standout
Extracellular vesicles in blood, milk and body fluids of the female and male urogenital tract and with special regard to reproduction
2016
Prevention of Venous Thromboembolism
2004 Standout
Sickle-cell disease
2010 Standout
Microbicides and HIV prevention: lessons from the past, looking to the future
2009
Elevated Plasma Factor VIII and D-Dimer Levels as Predictors of Poor Outcomes of Thrombosis in Children
2004
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 Standout
Autoreactivity and Exceptional CDR Plasticity (but Not Unusual Polyspecificity) Hinder Elicitation of the Anti-HIV Antibody 4E10
2013
Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1
2004
Factor V Leiden and prothrombin G20210A mutations in young adults with cryptogenic ischemic stroke
2004
Antithrombotic Therapy in Neonates and Children
2008
What We Talk About When We Talk About Fat
2014 Standout
Antithrombotic Therapy in Neonates and Children
2012
Disseminated Intravascular Coagulation
1999 Standout
Folate and human reproduction
2006
Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant
2011 StandoutNobel
Safety and outcomes of thrombolysis with tissue plasminogen activator for treatment of intravascular thrombosis in children
2001
Acute-Phase Proteins and Other Systemic Responses to Inflammation
1999 Standout
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Parvovirus B19
2004 Standout
Enhancing wound healing with growth factors
2002
Adipose Tissue as an Endocrine Organ
2004 Standout
Hemostasis and fibrinolysis in non-diabetic overweight and obese men and women. Is there still a role for leptin?
2006
The immunopathogenesis of sepsis
2002 StandoutNature
Factor V Leiden: A Clinical Review
2001
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
Development of the human coagulation system in the full-term infant
1987 Standout
Diagnosis and Management of the Metabolic Syndrome
2005 Standout
Risk Factors for Arterial Ischemic Stroke in Children
2000
Synthesis and Function of 3-Phosphorylated Inositol Lipids
2001 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Intracerebral Hemorrhage Associated With Oral Anticoagulant Therapy
2005
Factor V Leiden, Prothrombin Gene G20210A Variant, and Methylenetetrahydrofolate Reductase C677T Genotype in Young Adults With Ischemic Stroke
2001
Inhibitory Anti–Factor V Antibodies Bind to the Factor V C2 Domain and Are Associated With Hemorrhagic Manifestations
1998
Anticoagulation Monitoring during Cardiac Surgery
1999
Aggregation-Induced Emission: Together We Shine, United We Soar!
2015 Standout
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
2000
Thrombin generation, a function test of the haemostaticthrombotic system
2006
Prevention and Treatment of Thrombosis in Pediatric and Congenital Heart Disease
2013
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
The Hypercoagulable States
1985
Somatic inactivation of the PHD2 prolyl hydroxylase causes polycythemia and congestive heart failure
2007 StandoutNobel
A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce the risk of postthrombotic syndrome in children
2007
Obesity is associated with macrophage accumulation in adipose tissue
2003 Standout
Lipopolysaccharide Endotoxins
2002 Standout
Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S–C4b binding protein complex
2003
Broad Neutralization of Human Immunodeficiency Virus Type 1 (HIV-1) Elicited from Human Rhinoviruses That Display the HIV-1 gp41 ELDKWA Epitope
2009
Relationship between Antibody 2F5 Neutralization of HIV-1 and Hydrophobicity of Its Heavy Chain Third Complementarity-Determining Region
2009
Part 14: Pediatric Advanced Life Support
2010 Standout
Low-Dose Thrombin Injection to Treat Iatrogenic Femoral Artery Pseudoaneurysms
2001
Elicitation of structure-specific antibodies by epitope scaffolds
2010 StandoutNobel
Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline
2007
Works of W. Muntean being referenced
Danaparoid sodium (Orgaran®) in four children with heparin‐induced thrombocytopenia type II
2001
Microparticles in newborn cord blood: Slight elevation after normal delivery
2011
Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents
2000
Thrombophilic polymorphisms – factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations – and preterm birth
2004
Practical guidelines for the clinical use of plasma
2002
Coagulation and Anticoagulation in Extracorporeal Membrane Oxygenation
1999
Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data
2007
The Influence of Weight Loss on Fibrinolytic and Metabolic Parameters in Obese Children and Adolescents
2001
Serum cytokines in juvenile rheumatoid arthritis: correlation with conventional inflammation parameters and clinical subtypes
1995
Effects of short-term energy restriction and physical training on haemostatic risk factors for coronary heart disease in obese children and adolescents
2001
Signs of thrombin generation in pediatric cardiac catheterization with unfractionated heparin bolus or subcutaneous low molecular weight heparin for antithrombotic cover
2003
Inhibitor to factor V after exposure to fibrin sealant during cardiac surgery in a two‐year‐old child
1994
Correlation between cholesterol, soluble P-selectin, and D-dimer in obese children and adolescents
2000
Shorter PFA‐100® closure times in neonates than in adults: role of red cells, white cells, platelets and von Willebrand factor
2001
Recommendations for tPA Thrombolysis in Children
2002
Elevated Factor VIII Activity and Factor Vlll-related Antigen in Diabetic Children Without Vascular Disease
1982
Laboratory Testing for Thrombophilia in Pediatric Patients
2002
Age-dependency of thrombin generation measured by means of calibrated automated thrombography (CAT)
2006
Factor V Leiden and Prothrombin Gene G 20210 A Variant in Children with Ischemic Stroke
1998
Immunologic Studies of Prothrombin in Newborns
1979
Tissue plasminogen activator (alteplase) treatment for femoral artery thrombosis after cardiac catheterisation in infants and children.
1993
Severe Bleeding due to Factor V Inhibitor after Repeated Operations Using Fibrin Sealant Containing Bovine Thrombin
1997
Low total protein S antigen but high protein S activity due to decreased C4b-binding protein in neonates
1988
Laboratory testing for thrombophilia in pediatric patients. On behalf of the Subcommittee for Perinatal and Pediatric Thrombosis of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis (ISTH).
2002
Shorter PFA-100 Closure Times (CT) in Neonates than in Adults: Role of Red Cells, White Cells, Platelets, and von Willebrand Factor
2002
Effects of Heparin and Hirudin on Thrombin Generation and Platelet Aggregation after Intrinsic Activation of Platelet Rich Plasma
1995
Recombinant Tissue Plasminogen Activator Treatment in Two Infants With Fulminant Meningococcemia
1995